Contemporary issues on clopidogrel therapy: A critical appraisal

Internal and Emergency Medicine

Volumn 4, Issue 3, 2009, Pages 195-198

  Capodanno, Davide ^a   Angiolillo, Dominick J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

HEART MUSCLE ISCHEMIA; HUMAN; NOTE;

HUMANS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 67349215656     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-009-0241-8     Document Type: Note

References (19)

1. CAPRIE Steering Committee 1996 A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1329 1339 (Pubitemid 26383772)
2. S Yusuf F Zhao SR Mehta S Chrolavicius G Tognoni KK Fox 2001 Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 494 502 (Pubitemid 32758501)
3. ZM Chen LX Jiang YP Chen JX Xie HC Pan R Peto R Collins LS Liu COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group 2005 Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 1607 1621
4. MS Sabatine CP Cannon CM Gibson 2005 Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 1179 1189 (Pubitemid 40397259)
5. SR Mehta S Yusuf RJ Peters 2001 Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 527 533 (Pubitemid 32772726)
6. SR Steinhubl PB Berger JT Mann 3rd ET Fry A DeLago C Wilmer EJ Topol CREDO Investigators: Clopidogrel for the Reduction of Events During Observation. 2002 Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2411 2420 (Pubitemid 35340537)
7. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr, Jacobs AK, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B; American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 116:148-304
8. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, Hochman JS, Krumholz HM, Lamas GA, Mullany CJ, Pearle DL, Sloan MA, Smith SC Jr; 2004 Writing Committee Members, Anbe DT, Kushner FG, Ornato JP, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee
9. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO; 2005 WRITING COMMITTEE MEMBERS, Feldman TE, Kern MJ, O'Neill WW, Schaff HV, Whitlow PL, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Page RL, Riegel B, Tarkington LG, Yancy CW (2008) 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 117:261-295
10. DJ Angiolillo DL Bhatt PA Gurbel LK Jennings 2009 Advances in antiplatelet therapy: agents in clinical development Am J Cardiol 103 Suppl 40A 51A
11. Patti G, Di Sciascio G (2009) Contemporary issues on clopidogrel therapy. Intern Emerg Med. doi: 10.1007/s11739-008-0220-5
12. SR Steinhubl PB Berger DM Brennan EJ Topol CREDO Investigators 2006 Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention J Am Coll Cardiol 47 939 943 (Pubitemid 43312753)
13. G Patti G Colonna V Pasceri LL Pepe A Montinaro G DI Sciascio 2005 A randomized trial of high loading dose of clopidogrel for reduction of peri-procedural myocardial infarction in patients undergoing coronary intervention results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) study Circulation 111 2099 2106 (Pubitemid 40577905)
14. DJ Angiolillo S Suryadevara P Capranzano TA Bass 2008 Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development Expert Opin Pharmacother 9 2893 2900
15. Patti G, Colonna G, Pasceri V (2007) Is 600 mg in-lab clopidogrel loading equivalent to "upstream" pre-treatment in patients undergoing percutaneous coronary intervention? Results of the ARMYDA-5 (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized trial. Late breaking clinical trials, TCT sessions. http://www.cardiosource.com/img/ armyda501.ppt
16. P Widimsky Z Motovská S Simek P Kala R Pudil F Holm R Petr D Bílková H Skalická P Kuchynka M Poloczek R Miklík M Maly M Aschermann PRAGUE-8 Trial Investigators 2008 Clopidogrel pre-treatment in stable angina: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8 Eur Heart J 29 1495 1503
17. A Kastrati N von Beckerath A Joost G Pogatsa-Murray O Gorchakova A Schömig 2004 Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy Circulation 110 1916 1919 (Pubitemid 39331901)
18. DJ Angiolillo 2009 Variability in responsiveness to oral antiplatelet therapy Am J Cardiol 103 Suppl 27A 34A
19. DJ Angiolillo S Suryadevara P Capranzano MZ Zenni LA Guzman TA Bass 2009 Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists Catheter Cardiovasc Interv 73 1 14